Phlebotics

1 known investors

Phlebot is developing automated blood sampling (ABS) technology aimed at applying automation to blood collection, targeting intensive care medicine and longer-term research. Its stated goal is to reduce patient pain and labor while improving safety, accuracy, and reliability of blood collection; the technology is not yet an approved medical device for human use.